HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,275.00
+25.00 (0.59%)
Apr 24, 2026, 3:30 PM KST

HLB Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,29152,72516,76930,97831,254
Short-Term Investments
586.8816,21211,29812,35024,690
Trading Asset Securities
-10,62950,79388,66184,017
Cash & Short-Term Investments
13,87879,56678,860131,989139,961
Cash Growth
-82.56%0.90%-40.25%-5.70%-11.44%
Accounts Receivable
14,97518,12011,46413,07211,648
Other Receivables
1,9062,0572,3712,1161,123
Receivables
22,88420,18814,64616,20214,157
Inventory
6,7916,1035,26710,8671,769
Prepaid Expenses
1,081468.69448.74208.4281.34
Other Current Assets
1,0041,382238.851,509654.91
Total Current Assets
45,637107,70999,460160,776156,822
Property, Plant & Equipment
129,75381,20672,91892,08922,081
Long-Term Investments
226,153254,694146,03844,74924,346
Goodwill
8,275-1,77221,925-
Other Intangible Assets
43,33844,78054,02969,50662,809
Long-Term Accounts Receivable
---341.17363.96
Long-Term Deferred Charges
125.91----
Other Long-Term Assets
24,67650,50049,15822,2644,262
Total Assets
478,094539,017423,500411,790270,800
Accounts Payable
2,6826,9855,1609,38410,278
Accrued Expenses
2,8192,0292,240697.15717.82
Short-Term Debt
84,72728,153106,7617,920-
Current Portion of Long-Term Debt
18,38012,2767,060387.2-
Current Portion of Leases
920.17632.14922.332,145668
Current Income Taxes Payable
177.5352.67,555132.13-
Current Unearned Revenue
-2.9131.4938.4224.01
Other Current Liabilities
9,1113,4175,7276,0811,848
Total Current Liabilities
118,81553,547135,45726,78513,536
Long-Term Debt
54,47382,52951,410136,1893,500
Long-Term Leases
1,857193.33424.01832.41452.62
Pension & Post-Retirement Benefits
709.14568.2615.57683.58716.65
Long-Term Deferred Tax Liabilities
2,2082,3103,34510,0335,758
Other Long-Term Liabilities
2,2881,0451,0361,201224.73
Total Liabilities
180,351140,192192,288175,72424,188
Common Stock
61,43261,41651,40748,83148,223
Additional Paid-In Capital
320,197319,343168,141222,910240,895
Retained Earnings
-83,41616,37310,431-40,963-46,832
Treasury Stock
-679.97-679.97-679.97--
Comprehensive Income & Other
-1821,8891,4993,9473,904
Total Common Equity
297,351398,340230,797234,725246,189
Minority Interest
390.84484.91416.211,342422.87
Shareholders' Equity
297,742398,825231,213236,067246,612
Total Liabilities & Equity
478,094539,017423,500411,790270,800
Total Debt
160,357123,783166,578147,4734,621
Net Cash (Debt)
-146,479-44,217-87,718-15,484135,340
Net Cash Growth
-----7.71%
Net Cash Per Share
-1202.14-396.21-861.84-153.361362.33
Filing Date Shares Outstanding
121.55121.81101.896.71100.44
Total Common Shares Outstanding
121.55121.81101.8101.71100.44
Working Capital
-73,17954,162-35,997133,991143,286
Book Value Per Share
2446.403270.062267.232307.672451.22
Tangible Book Value
245,738353,561174,996143,294183,380
Tangible Book Value Per Share
2021.772902.451719.071408.781825.85
Land
27,49021,56921,47129,5809,065
Buildings
51,36223,22123,22119,9504,547
Machinery
75,80540,05639,21930,94912,906
Construction In Progress
1,24333,1018,47218,3901,324
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.